Cardiac tamponade complicating ventricular arrhythmia ablation: Real life data on incidence, management, and outcome.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
02 2023
Historique:
revised: 11 11 2022
received: 30 07 2022
accepted: 22 11 2022
pubmed: 27 11 2022
medline: 11 2 2023
entrez: 26 11 2022
Statut: ppublish

Résumé

Cardiac tamponade during ablation procedures is a life-threatening complication. While the incidence and management of tamponade in atrial fibrillation ablation have been extensively described, the data on tamponade during ventricular ablations are very limited. The purpose of this study is to shed light on the incidence, typical perforation sites, and optimal management as observed through real-life data in a tertiary referral center for ventricular ablation. Consecutive patients with structural heart disease undergoing ventricular tachycardia ablation from 2008-2020 were analyzed. Of the 1078 patients undergoing 1287 ventricular ablation procedures, 20 procedures (1.5%) were complicated by cardiac tamponade. In all but one patient, the tamponade was treated with emergent pericardial drainage, while nine patients eventually underwent surgical repair. The perforation occurred during transseptal or subxiphoid puncture in six patients, during ventricle mapping in two patients, and during ablation in five patients (predominantly basal left ventricle). Steam pop as definite perforation cause could only be established in two patients. Regardless of the management of the complication, all patients survived to discharge. Cardiac tamponade during ventricular ablation occurred in 1.5% of the procedures. In nine patients cardiac repair was necessary. Perforation was mostly associated with subxiphoid puncture or ablation of the basal left ventricle.

Sections du résumé

BACKGROUND AND OBJECTIVE
Cardiac tamponade during ablation procedures is a life-threatening complication. While the incidence and management of tamponade in atrial fibrillation ablation have been extensively described, the data on tamponade during ventricular ablations are very limited. The purpose of this study is to shed light on the incidence, typical perforation sites, and optimal management as observed through real-life data in a tertiary referral center for ventricular ablation.
METHODS AND RESULTS
Consecutive patients with structural heart disease undergoing ventricular tachycardia ablation from 2008-2020 were analyzed. Of the 1078 patients undergoing 1287 ventricular ablation procedures, 20 procedures (1.5%) were complicated by cardiac tamponade. In all but one patient, the tamponade was treated with emergent pericardial drainage, while nine patients eventually underwent surgical repair. The perforation occurred during transseptal or subxiphoid puncture in six patients, during ventricle mapping in two patients, and during ablation in five patients (predominantly basal left ventricle). Steam pop as definite perforation cause could only be established in two patients. Regardless of the management of the complication, all patients survived to discharge.
CONCLUSION
Cardiac tamponade during ventricular ablation occurred in 1.5% of the procedures. In nine patients cardiac repair was necessary. Perforation was mostly associated with subxiphoid puncture or ablation of the basal left ventricle.

Identifiants

pubmed: 36434796
doi: 10.1111/jce.15760
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

403-411

Informations de copyright

© 2022 The Authors. The Journal of World Intellectual Property published by John Wiley & Sons Ltd.

Références

Della Bella P, Baratto F, Vergara P, et al. Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter defibrillator? results from the multicenter randomized PARTITA trial. Circulation. 2022;145:1829-1838. doi:10.1161/CIRCULATIONAHA.122.059598
Tung R, Xue Y, Chen M, et al. First-line catheter ablation of monomorphic ventricular tachycardia in cardiomyopathy concurrent with defibrillator implantation: the PAUSE-SCD randomized trial. Circulation. 2022;145:1839-1849. doi:10.1161/CIRCULATIONAHA.122.060039
Stevenson WG, Richardson TD, Kanagasundram A. Ventricular tachycardia in 3 dimensions. J Am Coll Cardiol. 202075(8):898-900.
Bollmann A, Ueberham L, Schuler E, et al. Cardiac tamponade in catheter ablation of atrial fibrillation: german-wide analysis of 21141 procedures in the Helios atrial fibrillation ablation registry (SAFER). EP Europace. 2018;20(12):1944-1951.
Darma A, Bertagnolli L, Weber A, et al. Epicardial ablation of ventricular tachycardia in patients with structural heart disease: a single-centre experience over 12 years. EP Europace. 2021;23(12):1980-1988.
Sosa E, Scanavacca M, D'AVILA A, PILLEGGI E. A new technique to perform epicardial mapping in the electrophysiology laboratory. J Cardiovasc Electrophysiol. 1996;Jun 7(6):531-536.
Michowitz Y, Mathuria N, Tung R, et al. Hybrid procedures for epicardial catheter ablation of ventricular tachycardia: value of surgical access. Heart Rhythm. 2010;7:1635-1643.
Sawhney V, Breitenstein A, Ullah W, et al. Epicardial catheter ablation for ventricular tachycardia on uninterrupted warfarin: a safe approach for those with a strong indication for peri-procedural anticoagulation? Int J Cardiol. 2016;222:57-61.
Nakamura T, Davogustto GE, Schaeffer B, et al. Complications and anticoagulation strategies for percutaneous epicardial ablation procedures. Circulation. 2018;11(11):e006714.
Stevenson WG, Wilber DJ, Natale A, et al. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation. 2008;118:2773-2782.
Sauer WH, Zado E, Gerstenfeld EP, Marchlinski FE, Callans DJ. Incidence and predictors of mortality following ablation of ventricular tachycardia in patients with an implantable cardioverter-defibrillator. Heart Rhythm. 2010;7:9-14.
Della Bella P. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings. Eur Heart J. 2002;23:414-424.
Proietti R, Essebag V, Beardsall J, et al. Substrate-guided ablation of haemodynamically tolerated and untolerated ventricular tachycardia in patients with structural heart disease: effect of cardiomyopathy type and acute success on long-term outcome. Europace. 2015;17(3):461-467.
Muser D, Liang JJ, Pathak RK, et al. Long-term outcomes of catheter ablation of electrical storm in nonischemic dilated cardiomyopathy compared with ischemic cardiomyopathy. JACC. 2017;3(7):767-778.
Muser D, Santangeli P, Castro SA, et al. Long-Term outcome after catheter ablation of ventricular tachycardia in patients with nonischemic dilated cardiomyopathy. Circulation. 2016;9(10):e004328.
Mathew S, Fink T, Feickert S, et al. Complications and mortality after catheter ablation of ventricular arrhythmias: risk in VT ablation (RIVA) score. Clinical Research in Cardiology. 2022;111(5):530-540.
Hamaya R, Miyazaki S, Taniguchi H, et al. Management of cardiac tamponade in catheter ablation of atrial fibrillation: single-centre 15-year experience on 5222 procedures. EP Europace. 2018;20(11):1776-1782.
Arbelo E, Brugada J, Lundqvist CB, et al. Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry. Eur Heart J. 2017;38(17):ehw564.
Tokuda M, Kojodjojo P, Epstein LM, et al. Outcomes of cardiac perforation complicating catheter ablation of ventricular arrhythmias. Circulation. 2011;4(5):660-666.
Liuba I, Muser D, Chahal A, et al. Substrate characterization and outcome of catheter ablation of ventricular tachycardia in patients with nonischemic cardiomyopathy and isolated epicardial scar. Circulation. 2021;14(12):e010279.
Sugrue A, Maor E, Del-Carpio Munoz F, Killu AM, Asirvatham SJ. Cardiac ablation with pulsed electric fields: principles and biophysics. Europace. 2022;24(8):1213-1222.
Romero J, Shivkumar K, Di Biase L, et al. Mastering the art of epicardial access in cardiac electrophysiology. Heart Rhythm. 2019;16(11):1738-1749.
Smietana J, Supple G, Frankel D, et al. Continuous pericardial Irrigation-Suction technique to manage hemorrhagic pericardial effusion associated with loculated intrapericardial thrombus. J Am Coll Cardiol EP. 2022;8(9):1155-1157.
Fukasawa K, Umetani K, Yano T, Sano K. Constrictive pericarditis following atrial fibrillation catheter ablation with cardiac tamponade. HeartRhythm Case Rep. 2021;7(12):836-839.
Tarantino N, Della Rocca DG, Faggioni M, et al. Epicardial ablation complications. Cardiac Electrophysiol Clin. 202012(3):409-418.

Auteurs

Angeliki Darma (A)

Department of Cardiac Electrophysiology, Heart Centre of Leipzig, Leipzig, Germany.

Borislav Dinov (B)

Department of Cardiac Electrophysiology, Heart Centre of Leipzig, Leipzig, Germany.

Livio Bertagnolli (L)

Department of Cardiology and Electrophysiology, San Maurizio Hospital, Bolzano, Italy.

Federica Torri (F)

Department of Cardiology and Electrophysiology, San Maurizio Hospital, Bolzano, Italy.

Julia Anna Lurz (JA)

Department of Cardiac Electrophysiology, Heart Centre of Leipzig, Leipzig, Germany.

Nikolaos Dagres (N)

Department of Cardiac Electrophysiology, Heart Centre of Leipzig, Leipzig, Germany.

Andreas Bollmann (A)

Department of Cardiac Electrophysiology, Heart Centre of Leipzig, Leipzig, Germany.

Gerhard Hindricks (G)

Department of Cardiac Electrophysiology, Heart Centre of Leipzig, Leipzig, Germany.

Arash Arya (A)

Department of Cardiac Electrophysiology, Halle University, Halle, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH